This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Enblad, P. Articles by Persson, L. Search for Related Content PubMed PubMed Citation Articles by Enblad, P. Articles by Persson, L. Related Collections Animal models of human disease Ischemic biology - basic studies Acute Cerebral Infarction Brain Circulation and Metabolism PET and SPECT

(Stroke. 2001;32:1574.)
© 2001 American Heart Association, Inc.

Original Contributions

Middle Cerebral Artery Occlusion and Reperfusion in Primates Monitored by Microdialysis and Sequential Positron Emission Tomography

Per Enblad, MD, PhD; Peter Frykholm, MD; Johann Valtysson, MD, PhD; Hans C:son Silander, MD, PhD; Jesper Andersson, PhD; Karl-Johan Fasth, PhD; Yasuyoshi Watanabe, PhD; Bengt Långström, PhD; Lars Hillered, MD, PhD Lennart Persson, MD, PhD

From the Departments of Clinical Neurosciences/Neurosurgery (P.E., P.F., J.V., H.C.S., L.H., L.P.), Surgical Sciences/Anaesthesiology (J.V.), and Medical Sciences/Clinical Chemistry (L.H.), Uppsala University Hospital, the Uppsala University PET Centre (J.A., K.-J.F., Y.W., B.L.), and The Subfemtomole Biorecognition Project (J.A., K.-J.F., Y.W., B.L.), Uppsala, Sweden; and Japan Science and Technology Corp.

Correspondence to Per Enblad, MD, PhD, Department of Neuroscience, Section of Neurosurgery, University Hospital, S-751 85 Uppsala, Sweden. E-mail Per.Enblad{at}neurokir.uu.se

Background and Purpose—In a previous investigation concerning the hemodynamic and metabolic changes over time displayed by sequential positron emission tomography (PET) in a middle cerebral artery (MCA) occlusion/reperfusion primate model, a metabolic threshold for irreversible ischemia could be identified (reduction of metabolic rate of oxygen [CMRO₂] to 60% of the contralateral hemisphere). To evaluate the potential of microdialysis (MD) as an instrument for chemical brain monitoring, the aim of this subsequent study was to relate the chemical changes in MD levels directly to the regional metabolic status (CMRO₂ above or below the metabolic threshold) and the occurrence of reperfusion, as assessed by PET.

Methods—Continuous MD (2 probes in each brain) and sequential PET measurements were performed during MCA occlusion (2 hours) and 18 hours (mean) of reperfusion in 8 monkeys (Macaca mulatta). Energy-related metabolites (lactate, pyruvate, and hypoxanthine) and glutamate were analyzed. The MD probe regions were divided into 3 categories on the basis of whether CMRO₂ was below or above 60% of the contralateral region (metabolic threshold level) during MCA occlusion and whether reperfusion was obtained: severe ischemia with reperfusion (n=4), severe ischemia without reperfusion (n=4), and penumbra with reperfusion (n=5).

Results—The lactate/pyruvate ratio, hypoxanthine, and glutamate showed similar patterns. MD probe regions with severe ischemia and reperfusion and probe regions with severe ischemia and no reperfusion displayed high and broad peaks, respectively, during MCA occlusion, and the levels almost never decreased to baseline. Penumbra MD probe regions displayed only slight transient increases during MCA occlusion and returned to baseline.

Conclusions—This experimental study of focal ischemia showed that the extracellular changes of energy-related metabolites and glutamate differed depending on the ischemic state of the brain during MCA occlusion and depending on whether reperfusion occurred. If MD proves to be beneficial in clinical practice, it appears important to observe relative changes over time.

Key Words: microdialysis • middle cerebral artery occlusion • penumbra • reperfusion • tomography, emission computed • monkeys

This article has been cited by other articles:

				Y. Cui, H. Takamatsu, T. Kakiuchi, H. Ohba, Y. Kataoka, C. Yokoyama, H. Onoe, Y. Watanabe, T. Hosoya, M. Suzuki, et al. Neuroprotection by a Central Nervous System-Type Prostacyclin Receptor Ligand Demonstrated in Monkeys Subjected to Middle Cerebral Artery Occlusion and Reperfusion: A Positron Emission Tomography Study Stroke, November 1, 2006; 37(11): 2830 - 2836. [Abstract] [Full Text] [PDF]

				A. S. Sarrafzadeh, D. Haux, L. Ludemann, H. Amthauer, M. Plotkin, I. Kuchler, and A. W. Unterberg Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Correlative Microdialysis-PET Study Stroke, March 1, 2004; 35(3): 638 - 643. [Abstract] [Full Text] [PDF]

				A. Sarrafzadeh, D. Haux, O. Sakowitz, G. Benndorf, H. Herzog, I. Kuechler, and A. Unterberg Acute Focal Neurological Deficits in Aneurysmal Subarachnoid Hemorrhage: Relation of Clinical Course, CT Findings, and Metabolite Abnormalities Monitored With Bedside Microdialysis Stroke, June 1, 2003; 34(6): 1382 - 1388. [Abstract] [Full Text] [PDF]

				M. Takasawa, K. Kitagawa, T. Ohtsuki, N. Oku, K. Hashikawa, S. Sakoda, M. Hori, and M. Matsumoto Prominent Matched Hypoperfusion in an Intact Cerebellum after a Solitary Middle Cerebellar Peduncle Infarct AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1356 - 1358. [Abstract] [Full Text] [PDF]

				C. A. Molina, J. Montaner, S. Abilleira, J. F. Arenillas, M. Ribo, R. Huertas, F. Romero, and J. Alvarez-Sabin Time Course of Tissue Plasminogen Activator-Induced Recanalization in Acute Cardioembolic Stroke: A Case-Control Study Stroke, December 1, 2001; 32(12): 2821 - 2827. [Abstract] [Full Text] [PDF]

				P Frykholm, L Hillered, B Langstrom, L Persson, J Valtysson, Y Watanabe, and P Enblad Increase of interstitial glycerol reflects the degree of ischaemic brain damage: a PET and microdialysis study in a middle cerebral artery occlusion-reperfusion primate model J. Neurol. Neurosurg. Psychiatry, October 1, 2001; 71(4): 455 - 461. [Abstract] [Full Text] [PDF]